Differences in lower urinary tract symptoms, treatment and mortality among african-american and white elderly men

Journal of the National Medical Association

Volumn 100, Issue 10, 2008, Pages 1146-1152

  Howard, Daniel L ^a,b   Taylor, Yhenneko J ^a   Louie, E R ^a  

^a SHAW UNIVERSITY   (United States)

^b Institute for Health   (United States)

Author keywords

Healthcare; Infection; Racial disparities; Treatment; Urinary tract

Indexed keywords

DOXAZOSIN; FINASTERIDE; TERAZOSIN;

AGED; ARTICLE; CATHETERIZATION; COMORBIDITY; ETHNICITY; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY;

EID: 55349124026     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)31480-2     Document Type: Article

References (31)

1. Bertaccini A, Vassallo F, Martino F, et al. Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH. Eur Urol. 2001;40(suppl 1):13-18.
2. Levy A, Samraj GP. Benign prostatic hyperplasia: when to 'watch and wait,' when and how to treat. Cleve Clin J Med. 2007;74(suppl 3):S15-S20.
3. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306-1314.
4. Wei JT, Schottenfeld D, Cooper K, et al. The natural history of lower urinary tract symptoms in Black American men: Relationships with aging, prostate size, flow rate and bothersomeness. J Urol. 2001;165:1521-1525.
5. Reggio E, de Bessa Jr J, Junqueira RG, et al. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening. Inf J Impot Res. 2007; 19:492-495.
6. Girman CJ, Jacobsen SJ, Tsukamoto T, et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology. 1998;51:428-436.
7. Jepsen JV, Bruskewitz RC. Comprehensive patient evaluation for benign prostatic hyperplasia. Urology. 1998:51 (4A suppl):13-18.
8. Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol. 1999:162:1301-1306.
9. Howard DL, Edwards BG, Whitehead K, et al. Healthcare practices among blacks and whites with urinary tract symptoms. J Natl Med Assoc. 2007;99:404-411.
10. Howard DL, Edwards BG, Whitehead K, et al. Quality and severity of lower urinary tract symptoms among African American elders. J Health Disparities Res Pract. 2007;1:73-91.
11. Platz EA, Smit E, Curhan GC, et al. Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology. 2002;59:877-883.
12. Sarma AV, Wei JT, Jacobson DJ, et al. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology. 2003;61:1086-1091.
13. Joseph MA, Hariow SD, Wei JT, et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol. 2003;157:906-914.
14. Bernard SL. Racial differences in perceptions of access to healthcare among the elderly. New York and London: Garland Publishing; 1997.
15. Roehrborn CG. 5-alpha-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia. Rev Urol. 2003;5(suppl 5):S12-S21.
16. Underwood III W, Jackson J, Wei JT, et al. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer. 2005; 103:538-545.
17. Xia Z, Roberts RO, Schottenfeld D, et al. Trends in prostatectomy for benign prostatic hyperplasia among black and white men in the United States: 1980 to 1994. Urology. 1999;53:1154-1159.
18. Wasson JH, Bubolz TA, Lu-Yao GL, et al. Transurethralresection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol. 2000;164:1212-1215.
19. Nickel JC. The economics of medical therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia. Curr Urol Rep. 2006;7:282-287.
20. Issa MM, Runken MC, Grogg et al. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride. Am J Manag Care. 2007:13(suppl 1):S10-S16.
21. Kim CI, Chang HS, Kim BK, et al. Long-term results of medical treatment in benign prostatic hyperplasia. Urology. 2006;68:1015-1019.
22. Norg RJ, van de Beek K, Portegijs PJ, et al. The effectiveness of a treatment protocol for male lower urinary tract symptoms in general practice: a practical randomised controlled trial. Br J Gen Pract. 2006;56:938-944.
23. Marks LS. Use of Salpha-reductase inhibitors to prevent benign prostatic hyperplasia disease. Curr Urol Rep. 2006;7:293-303.
24. Hutchison A, Farmer R, Verhamme K, et al. The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries. Eur Urol. 2007;51:207-215.
25. MacDonald D, McNicholas TA. Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life. Drugs. 2003;63:1947-1962.
26. Zusman R. Patients with uncontrolled hypertension or concomitant hypertension and benign prostatic hyperplasia. Clin Cardiol. 2004;27:63-69.
27. Sue S, Dhindsa MK. Ethnic and racial health disparities research: issues and problems. Health Educ Behav. 2006;33:459-469.
28. American Cancer Society. Cancer facts & figures for African Americans: 2007-2008. Atlanta, GA; 2007.
29. Markland AD, Thompson IM, Ankerst DP, et al. Lack of disparity in lower urinary tract symptom severity between community-dwelling non-Hispanic white, Mexican-American, and African-American men. Urology. 2007;69:697-702.
30. Litman HJ, McKinlay JB. The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey. BJU Int. 2007;100:820-825.
31. Platz EA, Rimm EB, Kawachi I, et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol. 1999;149:106-115.